Batavia Biosciences Expands Its Viral Vector and GMP Facilities to Accommodate Increasing Market Demand
Today, Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands to accommodate the increasing market demand. - October 18, 2017
Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus
Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016
Press Releases 1 - 2 of 2